Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Gkotzamanidou · SciRah

Researcher profile · Semantic Scholar

M. Gkotzamanidou

Share profile

M. Gkotzamanidou — researcher profile on SciRah

h-index: 23
Works: 112
Citations: 1,889

Most-cited papers

Elevated circulating sclerostin correlates with advanced disease features and abnormal bone remodeling in symptomatic myeloma: Reduction post‐bortezomib monotherapy
E. Terpos, D. Christoulas, E. Katodritou, C. Bratengeier +8 more
2012International Journal of Cancer191 citations
Semantic Scholar
The role of novel agents on the reversibility of renal impairment in newly diagnosed symptomatic patients with multiple myeloma
M. Dimopoulos, M. Roussou, M. Gkotzamanidou, Nikitas Nikitas +6 more
2013Leukemia167 citations Open access
Semantic Scholar
Extensive bone marrow infiltration and abnormal free light chain ratio identifies patients with asymptomatic myeloma at high risk for progression to symptomatic disease
E. Kastritis, E. Terpos, L. Moulopoulos, M. Spyropoulou-Vlachou +8 more
2013Leukemia163 citations Open access
Semantic Scholar
Circulating cytokine levels, Epstein-Barr viremia and risk of acquired immunodeficiency syndrome-related non-Hodgkin lymphoma
Flora Zagouri, M. Roussou, E. Kastritis, Andreas Koureas +7 more
2011American journal of hematology/oncology153 citations Open access
Semantic Scholar
Circulating activin-A is elevated in patients with advanced multiple myeloma and correlates with extensive bone involvement and inferior survival; no alterations post-lenalidomide and dexamethasone therapy.
E. Terpos, E. Kastritis, D. Christoulas, M. Gkotzamanidou +4 more
2012Annals of Oncology102 citations Open access
Semantic Scholar
Diffuse pattern of bone marrow involvement on magnetic resonance imaging is associated with high risk cytogenetics and poor outcome in newly diagnosed, symptomatic patients with multiple myeloma: A single center experience on 228 patients
L. Moulopoulos, M. Dimopoulos, E. Kastritis, D. Christoulas +9 more
2012American journal of hematology/oncology95 citations Open access
Semantic Scholar
Diffuse MRI marrow pattern correlates with increased angiogenesis, advanced disease features and poor prognosis in newly diagnosed myeloma treated with novel agents
L. Moulopoulos, M. Dimopoulos, D. Christoulas, E. Kastritis +9 more
2010Leukemia67 citations
Semantic Scholar
High Circulating Sclerostin is Present in Patients with Thalassemia-associated Osteoporosis and Correlates with Bone Mineral Density
E. Voskaridou, D. Christoulas, E. Plata, C. Bratengeier +7 more
2012Hormone and Metabolic Research61 citations
Semantic Scholar
Increased serum lactate dehydrongenase should be included among the variables that define very-high-risk multiple myeloma.
M. Gkotzamanidou, E. Kastritis, M. Gavriatopoulou, Nikitas Nikitas +5 more
2011Clinical Lymphoma, Myeloma & Leukemia46 citations
Semantic Scholar
VTD consolidation, without bisphosphonates, reduces bone resorption and is associated with a very low incidence of skeletal-related events in myeloma patients post ASCT
E. Terpos, D. Christoulas, E. Kastritis, M. Roussou +8 more
2014Leukemia38 citations Open access
Semantic Scholar
Circulating angiopoietin‐1 to angiopoietin‐2 ratio is an independent prognostic factor for survival in newly diagnosed patients with multiple myeloma who received therapy with novel antimyeloma agents
E. Terpos, K. Anargyrou, E. Katodritou, E. Kastritis +14 more
2012International Journal of Cancer38 citations Open access
Semantic Scholar
The combination of lenalidomide and dexamethasone reduces bone resorption in responding patients with relapsed/refractory multiple myeloma but has no effect on bone formation: Final results on 205 patients of the Greek myeloma study group
E. Terpos, D. Christoulas, E. Kastritis, E. Katodritou +10 more
2014American journal of hematology/oncology36 citations Open access
Semantic Scholar
DNA repair of myeloma plasma cells correlates with clinical outcome: the effect of the nonhomologous end-joining inhibitor SCR7.
M. Gkotzamanidou, E. Terpos, C. Bamia, N. Munshi +2 more
2016Blood35 citations Open access
Semantic Scholar
Sclerostin: a possible target for the management of cancer-induced bone disease
M. Gkotzamanidou, M. Dimopoulos, E. Kastritis, D. Christoulas +2 more
2012Expert opinion on therapeutic targets34 citations
Semantic Scholar
Response to bortezomib of a patient with scleromyxedema refractory to other therapies.
M. Migkou, M. Gkotzamanidou, E. Terpos, M. Dimopoulos +1 more
2011Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis32 citations
Semantic Scholar
Renal impairment is not an independent adverse prognostic factor in patients with multiple myeloma treated upfront with novel agent-based regimens
Evangelos Eleftherakis-Papapiakovou, E. Kastritis, M. Roussou, M. Gkotzamanidou +5 more
2011Leukemia and Lymphoma32 citations
Semantic Scholar
The DNA damage response network in the treatment of head and neck squamous cell carcinoma
A. Psyrri, M. Gkotzamanidou, G. Papaxoinis, L. Krikoni +4 more
2021ESMO Open31 citations Open access
Semantic Scholar
Peripheral T-cell lymphoma: the role of hematopoietic stem cell transplantation.
M. Gkotzamanidou, C. Papadimitriou
2014Critical reviews in oncology/hematology30 citations
Semantic Scholar
Transcription factor-pathway co-expression analysis reveals cooperation between SP1 and ESR1 on dysregulating cell cycle arrest in non-hyperdiploid multiple myeloma
Xu-Jun Wang, Zhenyu Yan, M. Fulciniti, Yingxiang Li +6 more
2013Leukemia26 citations Open access
Semantic Scholar
Prognostic impact of indoleamine 2,3-dioxygenase 1 (IDO1) mRNA expression on circulating tumour cells of patients with head and neck squamous cell carcinoma
P. Economopoulou, Athina Kladi-Skandali, A. Strati, George Koytsodontis +13 more
2020ESMO Open25 citations Open access
Semantic Scholar
Chromatin structure, transcriptional activity and DNA repair efficiency affect the outcome of chemotherapy in multiple myeloma
M. Gkotzamanidou, P. Sfikakis, S. Kyrtopoulos, C. Bamia +2 more
2014British Journal of Cancer25 citations Open access
Semantic Scholar
Patterns of Response to Immune Checkpoint Inhibitors in Association with Genomic and Clinical Features in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)
P. Economopoulou, M. Anastasiou, G. Papaxoinis, N. Spathas +12 more
2021Cancers22 citations Open access
Semantic Scholar
Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer
M. Moutafi, G. Koliou, G. Papaxoinis, P. Economopoulou +28 more
2023Cancer Research Communications18 citations Open access
Semantic Scholar
Neutrophil Gelatinase--Associated Lipocalin and Cystatin C Are Sensitive Markers of Renal Injury in Patients With Multiple Myeloma.
Gerasimos-Petros Papassotiriou, E. Kastritis, M. Gkotzamanidou, D. Christoulas +8 more
2016Clinical Lymphoma, Myeloma & Leukemia17 citations
Semantic Scholar
Progressive changes in chromatin structure and DNA damage response signals in bone marrow and peripheral blood during myelomagenesis
M. Gkotzamanidou, E. Terpos, C. Bamia, S. Kyrtopoulos +3 more
2014Leukemia14 citations Open access
Semantic Scholar
Surrogates of immunologic cell death (ICD) and chemoradiotherapy outcomes in head and neck squamous cell carcinoma (HNSCC).
P. Economopoulou, G. Koutsodontis, A. Strati, Efthymios Kirodimos +13 more
2018Oral Oncology13 citations
Semantic Scholar
Development and validation of a PCR-based assay for the selection of patients more likely to benefit from therapeutic treatment with alkylating drugs.
D. Stefanou, H. Episkopou, S. Kyrtopoulos, A. Bamias +7 more
2012British Journal of Clinical Pharmacology12 citations Open access
Semantic Scholar
Increased expression of cyclin‐D1 on trephine bone marrow biopsies independently predicts for shorter overall survival in patients with multiple myeloma treated with novel agents
A. Tasidou, M. Roussou, E. Terpos, E. Kastritis +7 more
2012American journal of hematology/oncology12 citations
Semantic Scholar
Expression of CCL3 by neoplastic cells in patients with Waldenström's macroglobulinemia: an immunohistochemical study in bone marrow biopsies of 67 patients.
E. Terpos, A. Tasidou, E. Eleftherakis-Papaiakovou, D. Christoulas +6 more
2011Clinical Lymphoma, Myeloma & Leukemia11 citations
Semantic Scholar
Targeting the Interplay between HDACs and DNA Damage Repair for Myeloma Therapy
M. Gkotzamanidou, Elisavet Terpou, N. Kentepozidis, E. Terpos
2021International Journal of Molecular Sciences10 citations Open access
Semantic Scholar
Circulating Levels of the Wnt Inhibitors Dickkopf-1 and Sclerostin In Different Phases of Multiple Myeloma: Alterations Post-Therapy with Lenalidomide and Dexamethasone with or without Bortezomib
E. Terpos, D. Christoulas, M. Gkotzamanidou, C. Bratengeier +6 more
201010 citations
Semantic Scholar
Hematologic response and stabilization of renal function in a patient with light chain deposition disease after lenalidomide treatment: a novel therapeutic approach?
M. Gkotzamanidou, E. Terpos, E. Kastritis, M. Dimopoulos
2014Clinical Lymphoma, Myeloma & Leukemia8 citations
Semantic Scholar
Angiogenic cytokines profile in smoldering multiple myeloma: No difference compared to MGUS but altered compared to symptomatic myeloma
M. Gkotzamanidou, D. Christoulas, V. Souliotis, A. Papatheodorou +2 more
2013Medical Science Monitor8 citations Open access
Semantic Scholar
Tubular Damage Is Ubiquitous in Newly-Diagnosed Patients with Multiple Myeloma: Comparison of Three Urinary and Two Serum Markers of Kidney Injury.
M. Dimopoulos, D. Christoulas, E. Kastritis, M. Gkotzamanidou +5 more
20128 citations
Semantic Scholar
The Combination of Panobinostat and Melphalan for the Treatment of Patients with Multiple Myeloma
M. Gkotzamanidou, E. Terpos, M. Dimopoulos, V. Souliotis
2022International Journal of Molecular Sciences7 citations Open access
Semantic Scholar
Short progression‐free survival predicts for poor overall survival in older patients with multiple myeloma treated upfront with novel agent‐based therapy
M. Migkou, E. Kastritis, M. Roussou, M. Gkotzamanidou +7 more
2011European Journal of Haematology7 citations
Semantic Scholar
Semaphorin-4D and Plexin-B1 Are Elevated in Multiple Myeloma Microenvironment and Possibly Contribute in the Development of Lytic Bone Disease
E. Terpos, E. Kastritis, T. Bagratuni, D. Christoulas +6 more
20126 citations
Semantic Scholar
The Role of Novel Agents on Reversibility of Renal Impairment in Newly Diagnosed Patients with Multiple Myeloma; a Single Center Experience on 112 Patients,
M. Dimopoulos, M. Roussou, M. Gkotzamanidou, E. Psimenou +4 more
20116 citations
Semantic Scholar
Molecular correlates of response to preoperative olaparib alone or with cisplatin or with durvalumab in head and neck squamous cell carcinoma (HNSCC): A Hellenic Cooperative Oncology Group study.
A. Psyrri, G. Papaxoinis, N. Gavrielatou, M. Gkotzamanidou +8 more
20205 citations
Semantic Scholar
Blood-based testing of mutations in patients with head and neck squamous cell carcinoma (HNSCC) using highly sensitive SafeSEQ technology
F. Fostira, P. Oikonomopoulou, A. Kladi, D. Edelstein +11 more
2019Annals of Oncology4 citations Open access
Semantic Scholar
LSD1 Impairs the Epithelial-Mesenchymal Transition (EMT) and Osteoclastogenesis Potency in Multiple Myeloma and Synergistically Induces Cytotoxicity with HDAC Inhibitors
M. Gkotzamanidou, M. Fulciniti, J. Sánchez, M. Samur +3 more
20144 citations
Semantic Scholar
Elevated APE1 Mediates Dysregulation of Homologous Recombination in Myeloma: Mechanisms and Translational Significance
Subodh Kumar, M. Gkotzamanidou, Jagannath Pal, R. Lu +4 more
20143 citations
Semantic Scholar
Renal Impairment Is Not An Independent Adverse Prognostic Factor In Multiple Myeloma Patients Who Are Treated Upfront with Novel Agent-Based Regimens
M. Dimopoulos, E. Kastritis, M. Roussou, M. Gavriatopoulou +10 more
20103 citations
Semantic Scholar
Quantitative immunofluorescence and mRNA analysis of immune-related biomarker groups in matched paired tumor samples from OPHELIA window study in head and neck squamous cell carcinoma (HNSCC).
A. Psyrri, M. Moutafi, G. Koliou, G. Papaxoinis +15 more
20212 citations
Semantic Scholar
Clinical implications of hyperprogression with immune checkpoint inhibitors in patients with head and neck squamous cell carcinoma (HNSCC).
P. Economopoulou, N. Spathas, G. Papaxoinis, M. Anastasiou +8 more
2019Journal of Clinical Oncology2 citations
Semantic Scholar
HDAC8 Maintain Cytoskeleton Integrity Via Homologous Recombination and Represent a Novel Therapeutic Target in Multiple Myeloma
Z. Chyra, M. Gkotzamanidou, M. Shammas, V. Souliotis +6 more
2019Blood2 citations Open access
Semantic Scholar
Predictive biomarkers for response to nivolumab in head and neck squamous cell carcinoma (HNSCC) (NCT#03652142).
A. Psyrri, N. Gavrielatou, A. Spathis, M. Anastasiou +11 more
2019Journal of Clinical Oncology2 citations
Semantic Scholar
Abstract 3035: HDAC8 is recruited to DNA double strand breaks sites and affects the homologous recombination efficiency in multiple myeloma
M. Gkotzamanidou, M. Shammas, Jesús Martín Sánchez, M. Samur +6 more
20152 citations
Semantic Scholar
The State of Chromatin Condensation, the Expression of Genes Involved in DNA Damage Response and the DNA Repair Capacity Affect the Drug Sensitivity of PBMCs of Myeloma Patients Treated with Melphalan
M. Gkotzamanidou, E. Terpos, N. Munshi, V. Souliotis +1 more
20152 citations
Semantic Scholar
Ongoing Spontaneous DNA Damage and the Role of Aberrant Epigenome in Multiple Myeloma
M. Gkotzamanidou, M. Shammas, V. Souliotis, Wei-Hua Song +7 more
20142 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

E. Terpos×30
Invite
E. Terpos — researcher profile on SciRah
E. Kastritis×23
Invite
E. Kastritis — researcher profile on SciRah
M. Dimopoulos×20
Invite
M. Dimopoulos — researcher profile on SciRah
D. Christoulas×15
Invite
D. Christoulas — researcher profile on SciRah

M. Gavriatopoulou

×14

Invite

M. Gavriatopoulou — researcher profile on SciRah

Invite

M. Roussou — researcher profile on SciRah

Invite

M. Migkou — researcher profile on SciRah

Invite

A. Psyrri — researcher profile on SciRah

I. Kotsantis×10

Invite

I. Kotsantis — researcher profile on SciRah

M. Anastasiou×10

Invite

M. Anastasiou — researcher profile on SciRah

V. Souliotis×9

Invite

V. Souliotis — researcher profile on SciRah

P. Economopoulou×9

Invite

P. Economopoulou — researcher profile on SciRah